These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

750 related articles for article (PubMed ID: 7527326)

  • 1. Quinapril. A reappraisal of its pharmacology and therapeutic efficacy in cardiovascular disorders.
    Plosker GL; Sorkin EM
    Drugs; 1994 Aug; 48(2):227-52. PubMed ID: 7527326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quinapril: a further update of its pharmacology and therapeutic use in cardiovascular disorders.
    Culy CR; Jarvis B
    Drugs; 2002; 62(2):339-85. PubMed ID: 11817979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quinapril. A review of its pharmacological properties, and therapeutic efficacy in cardiovascular disorders.
    Wadworth AN; Brogden RN
    Drugs; 1991 Mar; 41(3):378-99. PubMed ID: 1711445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quinapril: a new second-generation ACE inhibitor.
    Cetnarowski-Cropp AB
    DICP; 1991 May; 25(5):499-504. PubMed ID: 2068835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical pharmacology of quinapril in healthy volunteers and in patients with hypertension and congestive heart failure.
    Sedman AJ; Posvar E
    Angiology; 1989 Apr; 40(4 Pt 2):360-9. PubMed ID: 2539762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overview of quinapril, a new ACE inhibitor.
    Frank GJ; Knapp LE; Olson SC; Phelps MC; Quade MM; Rieger MM; Sedman AJ
    J Cardiovasc Pharmacol; 1990; 15 Suppl 2():S14-23. PubMed ID: 1691402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose-related effects of ACE inhibition in man: quinapril in patients with moderate congestive heart failure. The Study Group on Neurohormonal Regulation in Congestive Heart Failure: Lausanne, Switzerland; Berlin, Düsseldorf, Munich, Germany.
    Nussberger J; Fleck E; Bahrmann H; Delius W; Schultheiss HP; Brunner HR
    Eur Heart J; 1994 Dec; 15 Suppl D():113-22. PubMed ID: 7713100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overview of the clinical development of quinapril.
    Frank GJ
    Clin Cardiol; 1990 Jun; 13(6 Suppl 7):VII13-8. PubMed ID: 2189616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Haemodynamic response and pharmacokinetics after the first dose of quinapril in patients with congestive heart failure.
    Squire IB; Macfadyen RJ; Lees KR; Hillis WS; Reid JL
    Br J Clin Pharmacol; 1994 Aug; 38(2):117-23. PubMed ID: 7981011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The safety and tolerability of quinapril.
    Knapp LE; Frank GJ; McLain R; Rieger MM; Posvar E; Singer R
    J Cardiovasc Pharmacol; 1990; 15 Suppl 2():S47-55. PubMed ID: 1691407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The safety profile of quinapril: is there a difference among ACE inhibitors?
    Canter D; Frank GJ; Knapp LE; McLain RW
    Clin Cardiol; 1990 Jun; 13(6 Suppl 7):VII39-42. PubMed ID: 2189620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Conversion from oral ACE inhibitor to intravenous quinaprilat administration in mild to moderate essential hypertension].
    Schmidt BM; Smilde J; Oldenbroek C; Wehling M
    Med Klin (Munich); 1998 Dec; 93(12):701-6. PubMed ID: 10024837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin converting enzyme inhibitors as initial monotherapy in severe hypertension. Quinapril and captopril.
    Frishman WH; Greenberg S
    Am J Hypertens; 1991 Oct; 4(10 Pt 1):827-31. PubMed ID: 1747216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ACE inhibitors in the treatment of hypertension in the older patient.
    Canter D; Frank G
    Eur Heart J; 1990 May; 11 Suppl D():33-43. PubMed ID: 2193809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does blood pressure reduction necessarily compromise cardiac function or renal hemodynamics? Effects of the angiotensin-converting enzyme inhibitor quinapril.
    Kjeldsen SE; Gupta RK; Krause L; Weder AB; Julius S
    Am Heart J; 1992 May; 123(5):1433-8. PubMed ID: 1575171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in pulmonary hemodynamics predict benefits in exercise capacity after ACE inhibition in patients with mild to moderate congestive heart failure.
    Pelliccia F; Borghi A; Ruggeri A; Cianfrocca C; Morgagni GL; Bugiardini R
    Clin Cardiol; 1993 Aug; 16(8):607-12. PubMed ID: 8370193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The management of hypertension in older patients.
    Schnaper HW
    J Cardiovasc Pharmacol; 1990; 15 Suppl 2():S56-61. PubMed ID: 1691408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multicentre, double-blind, placebo-controlled trial of quinapril in mild, chronic heart failure.
    Northridge DB; Rose E; Raftery ED; Lahiri A; Elder AT; Shaw TR; Henderson E; Dargie HJ
    Eur Heart J; 1993 Mar; 14(3):403-9. PubMed ID: 8458362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The treatment of moderate to severe hypertension with ACE inhibitors.
    Goldstein RJ
    J Cardiovasc Pharmacol; 1990; 15 Suppl 2():S29-35. PubMed ID: 1691404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative trial of quinapril versus captopril in mild to moderate congestive heart failure. Quinapril/Captopril Congestive Heart Failure Study Group.
    Gavazzi A; Marioni R; Campana C; Montemartini C
    J Hypertens Suppl; 1994 Jul; 12(4):S89-93. PubMed ID: 7965279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.